{"name":"Acrux DDS Pty Ltd","slug":"acrux-dds-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Testosterone MD-Lotion","genericName":"Testosterone MD-Lotion","slug":"testosterone-md-lotion","indication":"Hypogonadism in adult males","status":"phase_3"}]}],"pipeline":[{"name":"Testosterone MD-Lotion","genericName":"Testosterone MD-Lotion","slug":"testosterone-md-lotion","phase":"phase_3","mechanism":"Testosterone MD-Lotion delivers testosterone through the skin to replace deficient levels in the body.","indications":["Hypogonadism in adult males"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9rZk82YjY2cHRaQWFkWjdlNndhWi1JVC13WXRfcXY2aHdBd0hZMHhIenlsVmFIRlBRa0FqdXhGQnh6SnZacGRyVnJ3cjZFUHFiRGdHbDFSNjg5d0hiZTdTcXlRQTBUWTMzbWFEQUQ4THVzTC16MUE?oc=5","date":"2019-09-23","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Acrux Limited (ASX:ACR) - Shares, Dividends & News - intelligentinvestor.com.au","headline":"Acrux Limited (ASX:ACR) - Shares, Dividends & News","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}